A-K Bosserhoff - JoVE Visualize

Showing results (61-70 of 76) with videos related to

Pageof 8

Sort By:

Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 21, 2005

"Melanoma inhibitory activity" (MIA): a promising serological tumour marker in metastatic uveal melanomaI W Reiniger, U C Schaller, C Haritoglou, et al.

The Journal of Biological Chemistry|May 25, 2001

Induction of AP-2alpha expression by adenoviral infection involves inactivation of the AP-2rep transcriptional corepressor CtBP1M Schuierer, K Hilger-Eversheim, T Dobner, et al.

Oncogene|December 7, 2005

Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancerP P Aung, N Oue, Y Mitani, et al.

Oncogene|September 20, 2005

Expression of Hugl-1 is strongly reduced in malignant melanomaS Kuphal, S Wallner, C C Schimanski, et al.

Experimental Cell Research|November 1, 2005

Regulation of mesenchymal stem cell and chondrocyte differentiation by MIAG Tscheudschilsuren, A K Bosserhoff, J Schlegel, et al.

American Journal of Physiology. Gastrointestinal and Liver Physiology|January 17, 2004

Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cellsM Mühlbauer, B Allard, A K Bosserhoff, et al.

Journal of Clinical Pathology|March 28, 2006

Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarraysR Bauer, P J Wild, S Meyer, et al.

Rheumatology (Oxford, England)|May 26, 1999

MIA (melanoma inhibitory activity): a potential serum marker for rheumatoid arthritisU Müller-Ladner, A K Bosserhoff, K Dreher, et al.

Cancer Research|November 1, 1994

Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIAA Blesch, A K Bosserhoff, R Apfel, et al.

Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 2000

Deficiency of a novel retinoblastoma binding protein 2-homolog is a consistent feature of sporadic human melanoma skin cancerT Vogt, M Kroiss, M McClelland, et al.

Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:

Pageof 8

Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 21, 2005

"Melanoma inhibitory activity" (MIA): a promising serological tumour marker in metastatic uveal melanomaI W Reiniger, U C Schaller, C Haritoglou, et al.

The Journal of Biological Chemistry|May 25, 2001

Induction of AP-2alpha expression by adenoviral infection involves inactivation of the AP-2rep transcriptional corepressor CtBP1M Schuierer, K Hilger-Eversheim, T Dobner, et al.

Oncogene|December 7, 2005

Oncogene|September 20, 2005

Expression of Hugl-1 is strongly reduced in malignant melanomaS Kuphal, S Wallner, C C Schimanski, et al.

Experimental Cell Research|November 1, 2005

Regulation of mesenchymal stem cell and chondrocyte differentiation by MIAG Tscheudschilsuren, A K Bosserhoff, J Schlegel, et al.

American Journal of Physiology. Gastrointestinal and Liver Physiology|January 17, 2004

Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cellsM Mühlbauer, B Allard, A K Bosserhoff, et al.

Journal of Clinical Pathology|March 28, 2006

Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarraysR Bauer, P J Wild, S Meyer, et al.

Rheumatology (Oxford, England)|May 26, 1999

MIA (melanoma inhibitory activity): a potential serum marker for rheumatoid arthritisU Müller-Ladner, A K Bosserhoff, K Dreher, et al.

Cancer Research|November 1, 1994

Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIAA Blesch, A K Bosserhoff, R Apfel, et al.

Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 2000

Deficiency of a novel retinoblastoma binding protein 2-homolog is a consistent feature of sporadic human melanoma skin cancerT Vogt, M Kroiss, M McClelland, et al.

Pageof 8